Clinical Trial Update: The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine [NA]

View source ↗

Summary

Clinical trial update for the RIME Study evaluating combined occipital and supraorbital transcutaneous nerve stimulation for acute migraine; trial completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Neurolief Ltd. RIME Study device

Snippet

Sponsor: Neurolief Ltd. | Conditions: Acute Migraine | NA | Status: COMPLETED | Results posted: 2022-07-12